TipRanks
SAMSUNG BIOLOGICS Co., Ltd. (KR:207940)
:207940
South Korea Market
207940
SAMSUNG BIOLOGICS Co., Ltd.
RESEARCH TOOLSreports

SAMSUNG BIOLOGICS Co., Ltd. (207940) Ratios

1 Followers

SAMSUNG BIOLOGICS Co., Ltd. Ratios

KR:207940's free cash flow for Q2 2026 was ₩0.55. For the 2026 fiscal year, KR:207940's free cash flow was decreased by ₩ and operating cash flow was ₩0.44. See a summary of the company’s cash flow.
Ratios
TTM
Dec 25Dec 24Dec 23Dec 22
Liquidity Ratios
Current Ratio
 1.80 1.74 1.03 1.33 1.54
Quick Ratio
 1.01 0.90 0.50 0.69 0.98
Cash Ratio
 0.10 0.06 0.07 0.09 0.21
Solvency Ratio
 0.58 0.67 0.26 0.22 0.15
Operating Cash Flow Ratio
 0.82 0.89 0.31 0.40 0.23
Short-Term Operating Cash Flow Coverage
 5.99 7.03 5.07 1.20 0.84
Net Current Asset Value
₩ 1.04T₩ 798.74B₩ -913.50B₩ -693.72B₩ -1.14T
Leverage Ratios
Debt-to-Assets Ratio
 0.10 0.08 0.09 0.12 0.15
Debt-to-Equity Ratio
 0.15 0.12 0.14 0.19 0.28
Debt-to-Capital Ratio
 0.13 0.11 0.12 0.16 0.22
Long-Term Debt-to-Capital Ratio
 0.07 0.07 0.08 0.02 0.10
Financial Leverage Ratio
 1.51 1.48 1.59 1.63 1.85
Debt Service Coverage Ratio
 5.38 6.53 4.48 0.91 0.90
Interest Coverage Ratio
 73.83 70.93 26.40 13.65 15.35
Debt to Market Cap
 0.02 0.01 0.02 0.03 0.04
Interest Debt Per Share
 27.40K 20.70K 33.19K 43.01K 56.83K
Net Debt to EBITDA
 0.32 0.28 0.54 0.96 1.26
Profitability Margins
Gross Profit Margin
55.54%54.52%48.08%47.93%48.04%
EBIT Margin
54.00%47.13%41.03%30.14%32.77%
EBITDA Margin
64.97%61.04%58.16%43.40%43.04%
Operating Profit Margin
43.70%45.41%37.78%30.14%32.77%
Pretax Profit Margin
53.57%46.49%39.60%30.31%33.62%
Net Profit Margin
43.64%39.16%30.98%23.21%26.59%
Continuous Operations Profit Margin
39.90%35.43%29.75%23.21%26.59%
Net Income Per EBT
81.48%84.22%78.23%76.58%79.09%
EBT Per EBIT
122.57%102.39%104.81%100.57%102.58%
Return on Assets (ROA)
15.68%16.13%6.25%5.35%4.81%
Return on Equity (ROE)
22.10%23.95%9.93%8.72%8.88%
Return on Capital Employed (ROCE)
20.51%24.26%11.02%9.37%7.93%
Return on Invested Capital (ROIC)
14.67%17.81%7.97%6.36%5.69%
Return on Tangible Assets
15.78%16.22%9.20%8.40%7.51%
Earnings Yield
3.06%2.28%1.60%1.53%1.38%
Efficiency Ratios
Receivables Turnover
 6.03 5.84 2.81 4.97 3.66
Payables Turnover
 11.08 34.65 10.20 9.24 26.16
Inventory Turnover
 0.86 0.97 0.64 0.73 0.66
Fixed Asset Turnover
 0.67 0.75 0.60 0.85 0.78
Asset Turnover
 0.36 0.41 0.20 0.23 0.18
Working Capital Turnover Ratio
 2.12 2.57 4.56 2.03 1.50
Cash Conversion Cycle
 450.80 426.78 660.92 535.00 641.83
Days of Sales Outstanding
 60.48 62.48 130.12 73.37 99.74
Days of Inventory Outstanding
 423.28 374.83 566.58 501.14 556.04
Days of Payables Outstanding
 32.96 10.53 35.78 39.52 13.95
Operating Cycle
 483.76 437.31 696.70 574.52 655.78
Cash Flow Ratios
Operating Cash Flow Per Share
 52.58K 48.61K 35.84K 35.99K 21.01K
Free Cash Flow Per Share
 34.73K 18.51K 6.09K 12.12K -1.24K
CapEx Per Share
 17.85K 30.10K 29.76K 23.88K 22.25K
Free Cash Flow to Operating Cash Flow
 0.66 0.38 0.17 0.34 -0.06
Dividend Paid and CapEx Coverage Ratio
 2.95 1.62 1.20 1.51 0.94
Capital Expenditure Coverage Ratio
 2.95 1.62 1.20 1.51 0.94
Operating Cash Flow Coverage Ratio
 1.96 2.42 1.12 0.87 0.38
Operating Cash Flow to Sales Ratio
 0.54 0.49 0.47 0.45 0.32
Free Cash Flow Yield
2.48%1.09%0.42%1.00%-0.10%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 33.32 43.93 62.35 65.47 72.28
Price-to-Sales (P/S) Ratio
 14.55 17.20 19.31 15.20 19.22
Price-to-Book (P/B) Ratio
 7.91 10.52 6.19 5.71 6.42
Price-to-Free Cash Flow (P/FCF) Ratio
 41.15 91.55 239.75 100.12 -1.03K
Price-to-Operating Cash Flow Ratio
 27.18 34.87 40.71 33.70 60.52
Price-to-Earnings Growth (PEG) Ratio
 0.61 0.68 2.37 12.31 0.77
Price-to-Fair Value
 7.91 10.52 6.19 5.71 6.42
Enterprise Value Multiple
 22.71 28.46 33.75 35.98 45.90
Enterprise Value
 65.76T 79.16T 68.64T 57.70T 59.30T
EV to EBITDA
 22.26 28.46 33.75 35.98 45.90
EV to Sales
 14.46 17.37 19.63 15.62 19.76
EV to Free Cash Flow
 40.90 92.46 243.63 102.87 -1.06K
EV to Operating Cash Flow
 27.02 35.21 41.37 34.63 62.23
Tangible Book Value Per Share
 178.98K 159.84K 115.34K 86.38K 66.64K
Shareholders’ Equity Per Share
 180.64K 161.14K 235.57K 212.36K 198.06K
Tax and Other Ratios
Effective Tax Rate
 0.26 0.24 0.25 0.23 0.21
Revenue Per Share
 98.22K 98.55K 75.55K 79.81K 66.16K
Net Income Per Share
 42.87K 38.59K 23.40K 18.53K 17.59K
Tax Burden
 0.81 0.84 0.78 0.77 0.79
Interest Burden
 0.99 0.99 0.97 1.01 1.03
Research & Development to Revenue
 0.03 <0.01 0.01 0.02 0.05
SG&A to Revenue
 0.06 0.08 0.09 0.15 0.10
Stock-Based Compensation to Revenue
 0.00 0.00 0.00 0.00 0.00
Income Quality
 1.34 1.39 1.53 1.94 1.19
Currency in KRW